Metastatic Hormone Refractory Prostate Cancer Recruiting Phase 1 Trials for Niclosamide (DB06803)

Also known as: Metastatic hormone refractory Prostate cancer / Metastatic Prostate cancer / Prostate cancer metastatic / Metastatic Prostate Carcinoma / Carcinoma of the prostate metastatic / Prostatic cancer metastatic

IndicationStatusPhase
DBCOND0036371 (Metastatic Hormone Refractory Prostate Cancer)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03123978Enzalutamide and Niclosamide in Treating Patients With Recurrent or Metastatic Castration-Resistant Prostate CancerTreatment